Creative Planning’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.85M Sell
37,348
-2,977
-7% -$151K ﹤0.01% 2152
2026
Q1
$2.15M Buy
40,325
+32
+0.1% +$1.88K ﹤0.01% 1835
2025
Q4
$2.5M Buy
40,293
+128
+0.3% +$7.9K ﹤0.01% 1536
2025
Q3
$2.41M Buy
40,165
+131
+0.3% +$8.01K ﹤0.01% 1391
2025
Q2
$2.51M Buy
40,034
+9,537
+31% +$573K ﹤0.01% 1156
2025
Q1
$1.84M Buy
30,497
+1,685
+6% +$105K ﹤0.01% 1232
2024
Q4
$1.68M Buy
28,812
+8,439
+41% +$502K ﹤0.01% 1249
2024
Q3
$1.21M Sell
20,373
-423
-2% -$24.2K ﹤0.01% 1384
2024
Q2
$1.17M Sell
20,796
-434
-2% -$24.3K ﹤0.01% 1297
2024
Q1
$1.24M Sell
21,230
-724
-3% -$40.9K ﹤0.01% 1198
2023
Q4
$1.18M Sell
21,954
-3,245
-13% -$159K ﹤0.01% 1152
2023
Q3
$1.22M Sell
25,199
-12,660
-33% -$673K ﹤0.01% 1073
2023
Q2
$2.14M Buy
37,859
+16,739
+79% +$922K ﹤0.01% 787
2023
Q1
$1.14M Sell
21,120
-5,618
-21% -$299K ﹤0.01% 1012
2022
Q4
$1.41M Buy
26,738
+4,306
+19% +$219K ﹤0.01% 875
2022
Q3
$1.06M Sell
22,432
-1,340
-6% -$69.5K ﹤0.01% 943
2022
Q2
$1.2M Buy
23,772
+4,742
+25% +$258K ﹤0.01% 898
2022
Q1
$1.16M Sell
19,030
-3,744
-16% -$223K ﹤0.01% 920
2021
Q4
$1.5M Buy
22,774
+676
+3% +$43.3K ﹤0.01% 787
2021
Q3
$1.39M Sell
22,098
-4,572
-17% -$292K ﹤0.01% 802
2021
Q2
$1.6M Sell
26,670
-222
-0.8% -$12.8K ﹤0.01% 754
2021
Q1
$1.48M Buy
26,892
+420
+2% +$23.3K ﹤0.01% 844
2020
Q4
$1.44M Buy
26,472
+3,588
+16% +$188K ﹤0.01% 795
2020
Q3
$1.14M Buy
22,884
+4,578
+25% +$222K ﹤0.01% 744
2020
Q2
$808K Sell
18,306
-24
-0.1% -$1.03K ﹤0.01% 823
2020
Q1
$688K Sell
18,330
-594
-3% -$25K ﹤0.01% 800
2019
Q4
$834K Buy
18,924
+6,558
+53% +$276K ﹤0.01% 872
2019
Q3
$510K Buy
12,366
+1,488
+14% +$60.9K ﹤0.01% 1050
2019
Q2
$436K Sell
10,878
-408
-4% -$15.4K ﹤0.01% 1159
2019
Q1
$436K Buy
11,286
+420
+4% +$15.2K ﹤0.01% 1113
2018
Q4
$362K Sell
10,866
-420
-4% -$14.5K ﹤0.01% 1126
2018
Q3
$428K Buy
11,286
+2,106
+23% +$74.8K ﹤0.01% 1181
2018
Q2
$307K Buy
+9,180
New +$299K ﹤0.01% 1362
2017
Q3
Sell
-8,166
Closed -$227K 2751
2017
Q2
$227K Buy
8,166
+2,598
+47% +$68.8K ﹤0.01% 1447
2017
Q1
$141K Sell
5,568
-666
-11% -$16.1K ﹤0.01% 1726
2016
Q4
$138K Buy
6,234
+720
+13% +$16.3K ﹤0.01% 1639
2016
Q3
$134K Buy
5,514
+1,314
+31% +$31.3K ﹤0.01% 1642
2016
Q2
$95K Buy
4,200
+66
+2% +$1.43K ﹤0.01% 1711
2016
Q1
$84K Hold
4,134
﹤0.01% 1732
2015
Q4
$84K Sell
4,134
-4,212
-50% -$84.3K ﹤0.01% 1745
2015
Q3
$155K Buy
+8,346
New +$168K ﹤0.01% 1332
2015
Q2
Sell
-6,474
Closed -$130K 1992
2015
Q1
$130K Buy
6,474
+774
+14% +$15.1K ﹤0.01% 1427
2014
Q4
$107K Sell
5,700
-630
-10% -$11.4K ﹤0.01% 1523
2014
Q3
$105K Buy
6,330
+192
+3% +$3.27K ﹤0.01% 1440
2014
Q2
$104K Sell
6,138
-762
-11% -$12.5K ﹤0.01% 1405
2014
Q1
$114K Buy
6,900
+2,430
+54% +$39K ﹤0.01% 1321
2013
Q4
$69K Buy
4,470
+174
+4% +$2.6K ﹤0.01% 1409
2013
Q3
$61K Buy
4,296
+1,800
+72% +$24.7K ﹤0.01% 1392
2013
Q2
$33K Buy
+2,496
New +$32.3K ﹤0.01% 1619

Other funds holding IHI

Creative Planning's IHI Position: Q2 2026 in Review

Creative Planning reduced its iShares US Medical Devices ETF (IHI) stake by 7.4% in Q2 2026, selling an estimated $151K and leaving 37,348 shares worth $1.85M. The position accounts for ﹤0.01% of the portfolio, ranked #2152.

Creative Planning first reported a position in IHI in Q2 2013 and has held it in 49 quarters since. The position peaked at $2.51M in Q2 2025. 502 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

  • Creative Planning held 37,348 shares of iShares US Medical Devices ETF worth $1.85M as of Q2 2026.
  • Creative Planning sold 2,977 iShares US Medical Devices ETF shares in Q2 2026, an estimated $151K.
  • iShares US Medical Devices ETF made up ﹤0.01% of Creative Planning's portfolio in Q2 2026, its #2152 holding.
  • Creative Planning first reported a position in iShares US Medical Devices ETF in Q2 2013 and has held it in 49 quarters since.
  • Creative Planning's iShares US Medical Devices ETF position peaked at $2.51M in Q2 2025.
  • 502 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.